Westwood Holdings Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,067
Closed -$937K 468
2023
Q3
$937K Buy
9,067
+2,662
+42% +$297K 0.01% 349
2023
Q2
$778K Buy
6,405
+1,720
+37% +$229K 0.01% 361
2023
Q1
$720K Buy
+4,685
New +$773K 0.01% 378
2022
Q4
Sell
-5,588
Closed -$660K 586
2022
Q3
$660K Sell
5,588
-327
-6% -$49.6K 0.01% 349
2022
Q2
$844K Buy
5,915
+1,454
+33% +$208K 0.01% 357
2022
Q1
$769K Sell
4,461
-1,334
-23% -$225K 0.01% 372
2021
Q4
$1.47M Buy
+5,795
New +$1.69M 0.01% 321

Other funds holding MRNA

Westwood Holdings Group's MRNA Position: Q4 2023 in Review

Westwood Holdings Group sold out of Moderna (MRNA) in Q4 2023, closing a stake of 9,067 shares — an estimated $937K sold.

Westwood Holdings Group first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $1.47M in Q4 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Westwood Holdings Group reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 9,067 Moderna shares in Q4 2023, an estimated $937K.
  • Westwood Holdings Group first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • Westwood Holdings Group's Moderna position peaked at $1.47M in Q4 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Westwood Holdings Group's 13F filing for Q4 2023, filed 13 Feb 2024.